Jinan Chuancheng Pharmaceutical R&D Co., Ltd.

Bessifloxacin, a new type of fluoroquinolone developed by the company, is used for the treatment of bacterial conjunctivitis (a non viral infectious suppurative eye irritant conjunctivitis). Bacterial conjunctivitis is a contagious eye disease. It is a common disease that affects people of all ages. The clinical symptoms were characterized by foreign body sensation, burning sensation, tears, conjunctival congestion, mucous or purulent secretion, and severe cases with blepharoedema, conjunctiva edema and subconjunctival hemorrhage.